Gain Therapeutics (GANX)
Develops allosteric medicines and rexaceract for Parkinson’s disease.
$1.86
vs last close−0.10 (−4.87%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 49 days
EPS estimate
−$0.13
Revenue estimate
$33.3K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.11−$0.16−$0.19−$0.15−$0.11−$0.13−$0.11Pending
Estimate−$0.18−$0.16−$0.17−$0.15−$0.14−$0.13−$0.14−$0.13
Surprise+38.9%0.0%−11.8%0.0%+21.4%0.0%+20.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate—$25.0K——$25.0K$33.3K$33.3K$33.3K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.18 | — | — |
| Sep 2027 | −$0.20 | — | — |
| Jun 2027 | −$0.12 | — | — |
| Mar 2027 | −$0.13 | — | — |
| Dec 2026 | −$0.13 | — | — |
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.14 | −$0.11 | +20.3% |
| May 2026 | −$0.13 | −$0.13 | 0.0% |
| Mar 2026 | −$0.14 | −$0.11 | +21.4% |
| Nov 2025 | −$0.15 | −$0.15 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Dec 2020 | |||
| Mar 2021 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.18 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.20 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.12 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.13 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.13 | — | — | $33.3K | — | — | — |
| Nov 11, 2026 | −$0.13 | — | — | $33.3K | — | — | — |
| Aug 11, 2026 | −$0.14 | −$0.11 | +20.3% | $33.3K | — | — | +16.4% |
| May 11, 2026 | −$0.13 | −$0.13 | 0.0% | $33.3K | — | — | 0.0% |
| Mar 26, 2026 | −$0.14 | −$0.11 | +21.4% | $25.0K | — | — | −3.6% |
| Nov 12, 2025 | −$0.15 | −$0.15 | 0.0% | — | — | — | +10.1% |
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 10, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Mar 22, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |